Accelerate Diagnostics Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
54.13 M |
Public Float |
29.72 M |
Accelerate Diagnostics Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$1.65 |
Market Cap |
$1.28 B |
Shares Outstanding |
54.46 M |
Public Float |
29.78 M |
Address |
3950 South Country Club Road Tucson Arizona 85714 United States |
Employees | - |
Website | http://acceleratediagnostics.com |
Updated | 07/08/2019 |
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company was founded on May 26, 1982 and is headquartered in Tucson, AZ. |